Skip to content

Patients › Shoulder

Komprehensibong Arthroskopikong Pamamahala (CAM)

PDF Evidence

The Comprehensive Arthroscopic Management (CAM) procedure — a joint-preserving arthroscopic alternative to arthroplasty for glenohumeral osteoarthritis, combining debridement, capsular release, osteophyte excision, microfracture, loose-body removal and axillary nerve neurolysis.

Updated Jun 2026
Isang guhit-kamay na ilustrasyon ng isang manlalangoy sa gitna ng freestyle stroke.
Ang Comprehensive Arthroscopic Management ay nagpapanatili ng likas na kasukasuan — isang opsyon na nag-iwas sa pagtatanggal ng kasukasuan para sa mga mas batang, aktibong pasyente na may advanced na arthritis ng balikat. Kieran Hirpara 4.0

Ang pahinang ito ay isinalin ng makina at hindi pa nasusuri ng isang doktor. Ang bersyong Ingles ang siyang opisyal.

Bakit inirerekomenda ang operasyong ito

Ang pahinang ito ay nagpapakita kung paano ni Dr. Kieran Hirpara, isang surgeon para sa itaas na bahagi ng katawan sa Mater Private Hospital Rockhampton, inaangkop ang pamamaraan na ito sa aming klinika. Inirerekomenda namin ang Comprehensive Arthroscopic Management (CAM) para sa maagang pagkasira ng arthritis ng balikat. Karaniwang dumating sa aming klinika ang mga pasyente sa pamamagitan ng referral mula sa GP o physiotherapist. Isang pagsusuri sa klinika ang nagtatatag ng diagnosis. Para sa mga dehenratibong problema, karaniwang sinusubukan muna namin ang hindi operatibong paggamot. Isasalang-alang namin ang operasyon kapag hindi na ibinigay nito sapat na pagpapabuti.

Ang CAM ay isang pagpipilian na nagpapanatili ng kasukasuan para sa mga mas batang, aktibong pasyente na may advanced na osteoarthritis. Ang prosedura ay angkop kung mayroon kang higit sa 2 mm ng espasyo ng kasukasuan at walang makabuluhang deformity. Layunin ng prosedura na bawasan ang sakit at mapabuti ang pag-andar. Ipinapakita ng ebidensya na may 76.9% na survivorship rate sa loob ng hindi bababa sa 5 taon pagkatapos ng operasyon. Ibig sabihin, nananatiling buo ang kasukasuan nang hindi nangangailangan ng pagpapalit sa karamihan ng mga kaso. Ipinapakita namin ito bilang isang pagpupulong sa pagpili batay sa iyong partikular na mga pagkikita sa radiograph.

Bago ang operasyon

Mangyaring mag-fasting ng anim na oras bago ang iyong pagkakalagay sa prosedura. Itigil ang mga tiyak na blood thinner lamang pagkatapos ng payo ng iyong surgeon. Mag-arrange ng sakyanan pauwi at dalhin ang listahan ng lahat ng kasalukuyang gamot. Magsuot ng komportadong damit. Maaaring kailanganin ang X-ray, MRI, o blood tests bago ang operasyon. Ang mga scan na ito ay nagpapakita ng pagkasira ng kasu-kasuan, habang ang blood tests ay nagpapatunay sa iyong pangkalahatang kalusugan. Ang pagsusuri ng anaesthetist ay nagtitiyak na ligtas ka para sa operasyon. Gabay ng iyong surgeon ang mga hakbang na ito. Ang paghahanda na ito ay tumutulong sa amin na maayos na magplano ng iyong pag-aalaga. Nakakatulong din ito upang bawasan ang mga panganib sa panahon ng operasyon. Sundin nang mahigpit ang mga tiyak na instruksyon ng iyong surgeon.

Sa araw ng operasyon

Dadating ka sa ospital at magre-check in sa aming nursing team. Gabay namin ka papunta sa pre-op room para maghanda. Papakilala ka namin sa aming anestesiologo doon upang talakayin ang iyong plano sa paggamot. Ang operasyong ito ay isasagawa sa ilalim ng general anaesthetic na pinagsama ng regional nerve block. Ikaw ay ganap na matutulog habang ginagawa ang operasyon, at ang nerve block — isang injeksyon na nagpapabango sa mga nerbiyong nagpapadala ng sensasyon sa braso bago ka gumising — ay nagbibigay ng pagpapagaan ng sakit sa unang 12 hanggang 24 oras pagkatapos ng operasyon. Papakilala ka ng anestesiologo bago ang operasyon at ipapaliwanag niya ang dalawang bahagi nito.

Kapag nakapagpahinga ka na, dadalhin ka namin sa operating theatre. Ang aming team ang magpapatupad ng prosedura habang kumakalma ka. Kapag tapos na, dadalhin ka namin sa recovery area upang ligtas kang gumising. Magpapahinga ka doon habang sinusubaybayan ng aming staff ang iyong kaginhawaan at mga vital signs. Maaaring maramdaman mong magulo ang isip sa simula, ngunit dapat ay mananatiling manageable ang sakit dahil sa nerve block. Regular kaming magche-check upang matiyak na stable ka na bago ka ibalik sa iyong silid o pumunta sa bahay, depende sa iyong pag-unlad sa paggaling.

Ano ang kinabibilangan ng operasyon

Ang Comprehensive Arthroscopic Management ay isang keyhole surgery na dinisenyo upang gamutin ang maagang wear-and-tear arthritis sa iyong shoulder joint. Gumagamit kami ng maliliit na camera at mga instrument na ipinapasok sa pamamagitan ng maliliit na putol sa balat, imbes na isang malaking incision. Ang paraang ito ay nagbibigay-daan sa amin na makita nang malinaw ang loob ng joint habang pinapanatili ang minimal na trauma sa mga kalamnan at balat ng iyong balikat.

Sa loob ng proseso, sistematikong tinutugunan namin ang mga partikular na isyu na nagdudulot ng iyong sakit. Tinatanggal namin ang nasirang tissue at pinapakinis ang magaspang na gilid ng mga ibabaw ng buto. Kung mayroong maluwag na fragment o inflamed na tissue, linisin namin ito upang mapabuti ang galaw. Sa ilang kaso, maaari naming i-resurface ang socket ng shoulder joint upang maibalik ang mas makinis na ibabaw para sa ball ng upper arm bone na mag-slide laban dito. Nagre-release din kami ng mga mahigpit na tissue na maaaring nakakapag-limita sa iyong range of motion.

Ang paraang ito ay naaayon sa iyong partikular na anatomy. Sinusuri namin kung mayroon kang sapat na joint space at kung tama ang alignment ng mga buto. Kung ang iyong joint space ay mas mababa sa 2 mm o kung may malaking deformity, maaari naming talakayin ang ibang mga opsyon, tulad ng joint replacement, dahil maaaring hindi angkop ang mga keyhole techniques na ito. Gayundin, kung mayroon kang malalaking bone spurs sa harap ng balikat, maaari naming irekomenda ang ibang proseso.

Kapag tapos na ang trabaho sa loob ng joint, isasara namin ang maliliit na putol gamit ang mga tahi o pandikit at maglalagay ng dressing. Ang layunin ay mapanatili ang iyong natural na joint at maantala ang pangangailangan para sa mas invasive na surgery. Layunin naming bawasan ang iyong sakit at mapabuti ang iyong function, lalo na kung ikaw ay mas bata at aktibo. Ang paraang ito ay nag-aalok ng isang predictable na short-term na opsyon para sa pamamahala ng advanced arthritis nang hindi pinalitan ang joint.

Pagkatapos ng operasyon

Gising ka sa recovery ward. Pinamamahalaan namin ang iyong sakit gamit ang pangkalahatang gamot. Mananatili ang iyong balikat sa sling at may dressing para sa suporta. Panatilihing malinis at tuyo ang lugar. Karamihan sa mga pasyente ay nananatili ng isang gabi sa ospital pagkatapos ng operasyong ito, bagama't may ilang makakapagpunta sa bahay sa parehong araw. Kailangan mong may kasamang tao na manatili sa iyo sa loob ng unang 24 na oras. Huwag magmaneho habang naka-sling o kumakain ng gamot pang-alis ng sakit. Maaari kang magmaneho kapag pinapayagan ka ng iyong surgeon, karaniwan ay sa pagsusuri sa anim na linggo. Tingnan ang aming gabay tungkol sa Pagmamaneho pagkatapos ng surgery sa itaas na bahagi ng katawan para sa kumpletong detalye.

Pagbawi

Marami kang mapapansin na pamamaga at katigasan sa mga araw pagkatapos ng iyong operasyon. Ito ay normal na bahagi ng proseso ng paggaling. Pinamamahalaan namin ang hindi komportableng nararamdaman gamit ang mga iniresturang gamot at yelo. Panatilihin ang iyong braso sa itaas habang nakahiga upang matulungan ang pagbaba ng pamamaga. Karamihan sa mga pasyente ay nakakaramdam na ang matulis na sakit ay nagiging mahinang sakit sa loob ng unang ilang linggo.

Magdudulot ka ng sling upang protektahan ang iyong balikat habang ito ay gumagaling. Gabay namin ka sa mga banayad na ehersisyo ng pisikal na terapiya upang muling makuha ang galaw at lakas. Hindi ka dapat magmaneho habang nakasuot ng sling o kung ang sakit ay nakakapaglimita sa iyong oras ng reaksyon. Ayon sa aming patakaran, kailangan mong maghintay ng hindi bababa sa anim na linggo pagkatapos ng anumang operasyon sa balikat bago magmaneho, anuman ang braso na ginamutan. Maaari kang magmaneho muli kapag pinahintulutan ka ng iyong doktor, karaniwan sa pagsusuri sa anim na linggo. Para sa karagdagang detalye, tingnan ang aming gabay tungkol sa Pagmamaneho pagkatapos ng operasyon sa itaas na bahagi ng katawan.

Ang mga pang-araw-araw na gawain ay nagbabago habang gumagaling ka. Kailangan mong tulong sa mga gawain tulad ng pagluluto o pagsusuot ng damit sa simula. Habang bumabalik ang iyong galaw, maaari kang dahan-dahang muling magsimula ng magaan na gawaing bahay. Iwasan ang mabigat na pag-aangat o pag-abot sa itaas hangga't hindi pa inirerekomenda ng iyong pisikal na terapeuta na ligtas. Maaaring magkaiba ang iyong timeline; ang iyong doktor at pisikal na terapeuta ang gabay mo sa bawat yugto ng pagbawi.

Maaaring mangyari

Karamihan sa mga pasyente ay magagaling, ngunit minsan ay maaaring magkaroon ng mga problema. Ang iyong surgeon at ang koponan ay masusing susubaybayan ka upang maagang matukoy ang anumang isyu.

Kung mayroon kang osteoarthritis (wear-and-tear arthritis) sa shoulder joint, karaniwang nakakatulong ang arthroscopic treatment upang mas gumalaw ka nang maayos at mas mabawasan ang sakit. Bihirang mangyari ang mga seryosong problema. Gayunpaman, hindi ito palaging ang tamang pagpipilian para sa lahat. Kulang ito sa matibay na ebidensya na epektibo ito para sa karaniwang paggamot sa arthritis. Kung hindi bumababa ang iyong sakit, o kung nananatiling matigas ang iyong galaw, maaaring ito ay senyales na hindi nakatulong ang proseso gaya ng inaasahan. Dapat mong talakayin ang mga patuloy na sintomas na ito sa iyong surgeon sa susunod mong review upang magdesisyon tungkol sa mga susunod na hakbang.

Kung ikaw ay nasa proseso ng arthroscopic stabilization upang ayusin ang loose joint, maaaring mag-iba-iba ang resulta. May mga taong naramdaman ang katatagan at walang sakit, habang may iba pa ring nararanasan ang instability o discomfort. Dahil magkakaiba ang mga resulta, mahalagang maging mapanuri sa pakiramdam ng iyong shoulder habang nagre-recover. Kung mapansin mo ang pakiramdam ng clicking, grinding, o slipping kapag gumagalaw ka ng iyong braso, ipaalam ito sa iyong surgeon. Ang feedback na ito ay tumutulong sa kanila na maunawaan kung nananatiling matibay ang stabilization o kung kailangan pa ng karagdagang pagsusuri.

Para sa mga may massive rotator cuff tears, maaaring magbigay ng short-term relief ang arthroscopic debridement (paglilinis ng nasirang tissue). Hindi pa ganap na malinaw ang mga epekto sa pangmatagalan. Kung napansin mong mabilis bumabalik ang iyong sakit, o kung hindi umuunlad ang iyong lakas sa paglipas ng panahon, maaaring ito ay nagpapahiwatig na hindi nagbigay ng pangmatagalang benepisyo ang paglilinis. Mag-iwan ng tala sa iyong araw-araw na pagganap at ibahagi ang anumang setback sa iyong care team upang ma-adjust nila ang iyong plano.

Sa napakabihira nang mga kaso, maaaring magdulot ang isang seryosong impeksyon sa joint ng post-infectious arthritis. Ibig sabihin nito, permanenteng pinsala sa mga ibabaw ng joint pagkatapos ng isang seryosong impeksyon. Kasama sa mga senyales ang matinding, malalim na sakit na hindi bumababa kahit may simple na painkillers, malaking pamamaga, at pamumula na kumakalat mula sa sugat. Kung ikaw ay nag-aalala ng impeksyon, pumunta sa emergency department o tumawag agad sa iyong surgeon. Kritikal ang maagang paggamot upang maiwasan ang permanenteng pinsala sa joint.

Ang table ng mga komplikasyon sa pahinang ito ay naglalaman ng mga karaniwang rate kung nais mo ng mga detalye.

Kailan tawagan ang aming klinika

Tawagan kami kung may lagnat, lumalalang pamumula o paglabas ng likido sa sugat, o biglaang matinding sakit. Pumunta sa emergency room kung may pamamaga sa binti o hirap sa paghinga. Tawagan agad kung mawalan ng pakiramdam o hindi makagalaw ang iyong kamay o paa. Huwag magmaneho ng hindi bababa sa anim na linggo pagkatapos ng iyong operasyon. Makipag-ugnayan sa amin kapag pinahintulutan ka ng iyong doktor, karaniwan sa pagsusuri sa ika-anim na linggo.

Reviewed by Dr Kieran Hirpara · 7 August 2026.

Want the clinical detail? Read the clinician version.

Talk to your treating clinician for advice specific to you.

For an appointment with the CQ Hand + Upper Limb team, ask your GP about a referral or visit www.cqupperlimb.com.

Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

  • The Comprehensive Arthroscopic Management (CAM) procedure is a systematic, inclusive approach to the array of pathologies encountered in early glenohumeral arthritis [1].
  • The CAM procedure provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis by reducing pain and improving function [2].
  • The CAM procedure reduced pain, improved function, and provided reasonable short-term durability for young, active patients with advanced shoulder OA, serving as a joint-preserving alternative to arthroplasty [3].
  • Arthroscopic debridement improved clinical outcome in 68% of patients suffering from advanced OA of the glenohumeral joint [5].
  • The CAM procedure demonstrated significant improvements in midterm clinical outcomes and high patient satisfaction after the procedure for glenohumeral osteoarthritis, with a 76.9% survivorship rate at a minimum of 5 years postoperatively [6].
  • Treatment of glenohumeral arthritis with arthroscopic glenoid resurfacing provided superior results compared to previously performed arthroscopic procedures in patients with failed previous arthroscopic debridement [7].
  • CAM is a reasonable option for patients with localized cartilage defects and specific radiographic findings [10].
  • Hemiarthroplasty (HA) or total shoulder arthroplasty (TSA) are feasible options for patients with humeral head incongruity or large anterior osteophytes [10].
  • Arthroscopic debridement is an excellent treatment for elderly patients with modest functional demands, though long-term consequences require further evaluation [11].
  • Isolated arthroscopic debridement and capsular release may not provide substantial benefit to justify its use in most patients with glenohumeral arthritis [12].
  • Surgical arthroscopic repair was possible in all cases of acute or recurrent instability in soccer goalkeepers with well-defined exclusion criteria [14].

Anatomy & Pathophysiology

  • The CAM procedure is a systematic, inclusive approach to the array of pathologies encountered in early glenohumeral arthritis [1].
  • Advanced glenohumeral osteoarthritis is characterized by joint space loss and abnormal posterior glenoid shape [9].
  • Humeral head flattening and severe joint incongruity are identified as risk factors for failure in patients undergoing arthroscopic treatment for glenohumeral osteoarthritis [22].

Classification

  • Comprehensive Arthroscopic Management (CAM) is defined as a systematic, inclusive approach to the array of pathologies encountered in early glenohumeral arthritis [1].
  • CAM provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis [2].
  • CAM serves as a joint-preserving alternative to arthroplasty for young, active patients with advanced shoulder osteoarthritis [3].
  • Arthroscopic debridement improved clinical outcomes in 68% of patients suffering from advanced osteoarthritis of the glenohumeral joint [5].
  • CAM achieves significant improvements in midterm clinical outcomes and high patient satisfaction after the procedure for glenohumeral osteoarthritis [6].
  • The survivorship rate of the arthroscopic CAM procedure is 76.9% at a minimum of 5 years postoperatively [6].
  • Arthroscopic glenoid resurfacing provides superior results for the treatment of glenohumeral arthritis compared to previously performed arthroscopic procedures [7].
  • An arthroscopic approach to glenohumeral arthritis using various joint-preserving procedures reduces pain, improves function, and improves clinical outcome scores in the short- to mid-term follow-up period [8].
  • The CAM procedure reliably improves pain and function in active patients with advanced glenohumeral osteoarthritis [9].
  • Patients with less joint space and abnormal posterior glenoid shape are significantly more likely to progress to early failure after the CAM procedure [9].
  • Hemiarthroplasty or total shoulder arthroplasty are feasible options for patients with humeral head incongruity or large anterior osteophytes [10].
  • Arthroscopic debridement for glenohumeral arthritis lacks high-quality evidence to support its routine use [13].
  • Surgical arthroscopic repair is possible for acute or recurrent instability with well-defined exclusion criteria [14].
  • Comprehensive arthroscopic management without axillary nerve release or subacromial decompression achieves satisfactory and durable results in young patients with glenohumeral osteoarthritis [15].

Clinical Presentation

  • Comprehensive Arthroscopic Management (CAM) is recommended for the array of pathologies encountered in early glenohumeral arthritis [1].
  • The CAM procedure demonstrates significant improvements in midterm clinical outcomes and high patient satisfaction for glenohumeral osteoarthritis [6].
  • The CAM procedure has a 76.9% survivorship rate at a minimum of 5 years postoperatively [6].
  • Arthroscopic glenoid resurfacing provided superior results compared to previously performed arthroscopic procedures for treating glenohumeral arthritis [7].
  • Total shoulder arthroplasty (TSA) or hemiarthroplasty (HA) are feasible options for patients with humeral head incongruity or large anterior osteophytes [10].
  • Arthroscopic debridement is an excellent treatment for elderly patients with modest functional demands [11].
  • Arthroscopic treatment of glenohumeral osteoarthritis provides improvements in range of motion and patient-reported outcomes with minimal complications [17].
  • Arthroscopic debridement with capsular release may provide a window of improved symptoms and function before joint deterioration leads to more significant operations, especially in younger patients with mild or moderate osteoarthritic changes [19].
  • Arthroscopic debridement and biological resurfacing of the glenoid is a minimally invasive therapeutic option for pain relief, functional improvement, and patient satisfaction in glenohumeral osteoarthritis in the intermediate-term [20].

Investigations

  • The Comprehensive Arthroscopic Management (CAM) procedure is recommended as a systematic, inclusive approach to pathologies encountered in early glenohumeral arthritis [1].
  • CAM provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis by reducing pain and improving function [2].
  • The CAM procedure reduces pain, improves function, and provides reasonable short-term durability for young, active patients with advanced shoulder osteoarthritis, serving as a joint-preserving alternative to arthroplasty [3].
  • Arthroscopic stabilization results are variable, requiring individual analysis of each technique to determine the role of arthroscopy in glenohumeral stabilization [4].
  • The CAM procedure demonstrates significant improvements in midterm clinical outcomes and high patient satisfaction, with a 76.9% survivorship rate at a minimum of 5 years postoperatively [6].
  • Arthroscopic glenoid resurfacing provided superior results compared to previously performed arthroscopic procedures for the treatment of glenohumeral arthritis [7].
  • CAM is a reasonable option for patients with localized cartilage defects and specific radiographic findings, while hemiarthroplasty (HA) or total shoulder arthroplasty (TSA) are feasible options for those with humeral head incongruity or large anterior osteophytes [10].
  • Arthroscopic debridement is an excellent treatment for elderly patients with massive rotator cuff tears and modest functional demands, though long-term consequences require further evaluation [11].
  • Surgical arthroscopic repair is possible for acute or recurrent instability in soccer goalkeepers with well-defined exclusion criteria [14].
  • Arthroscopic debridement, facetectomy, and synovectomy aim to decrease pain originating from the patellofemoral joint by eliminating pain sources from the subchondral bone and synovium [21].
  • The survivorship rate of the CAM procedure at minimum 10-year follow-up is 63.2%, with humeral head flattening and severe joint incongruity identified as risk factors for failure [22].
  • Progressive radiographic osteoarthritic changes following arthroscopic debridement of massive irreparable rotator cuff tears do not negatively influence clinical results [27].

Treatment

  • Comprehensive Arthroscopic Management (CAM) is recommended as a systematic, inclusive approach for the array of pathologies encountered in early glenohumeral arthritis [1].
  • CAM reduces pain, improves function, and provides reasonable short-term durability for young, active patients with advanced shoulder osteoarthritis, serving as a joint-preserving alternative to arthroplasty [3].
  • Arthroscopic stabilization results are variable, and each technique must be analyzed individually to determine the role of arthroscopy in glenohumeral stabilization [4].
  • The arthroscopic CAM procedure for glenohumeral osteoarthritis demonstrates significant improvements in midterm clinical outcomes and high patient satisfaction, with a 76.9% survivorship rate at a minimum of 5 years postoperatively [6].
  • Arthroscopic glenoid resurfacing provided superior results for the treatment of glenohumeral arthritis compared to previously performed arthroscopic procedures in patients with failed prior debridement [7].
  • The CAM procedure reliably improves pain and function in active patients with advanced glenohumeral osteoarthritis, but patients with less joint space and abnormal posterior glenoid shape are significantly more likely to progress to early failure [9].
  • CAM is a reasonable option for patients with primary glenohumeral arthritis younger than 50 years old who have localized cartilage defects and specific radiographic findings [10].
  • Total shoulder arthroplasty or hemiarthroplasty are feasible options for patients with primary glenohumeral arthritis younger than 50 years old who have humeral head incongruity or large anterior osteophytes [10].
  • Most perioperative costs associated with the arthroscopic treatment of glenohumeral instability are facility utilization and implant costs [26].

Complications

  • Arthroscopic treatment of glenohumeral osteoarthritis provides improvements in ROM and patient-reported outcomes with minimal complications [17].
  • The majority of patients demonstrated sustained improvement in patient-reported outcomes and satisfaction without conversion to total shoulder arthroplasty at long-term follow-up, although some patients progressed to arthroplasty [16].
  • After the CAM procedure, 76.9% survivorship was observed at a minimum of 5 years postoperatively [6].
  • After the CAM procedure, 84% survivorship was found at 3 years and 72% survivorship at 5 years [30].

Recovery

  • The CAM procedure reduced pain, improved function, and provided reasonable short-term durability for young, active patients with advanced shoulder OA [3].
  • The CAM procedure serves as a joint-preserving alternative to arthroplasty for young, active patients with advanced shoulder OA [3].
  • The CAM procedure reliably improves pain and function in active patients with advanced glenohumeral osteoarthritis (GHOA) [9].
  • Patients with less joint space are significantly more likely to progress to early failure after the CAM procedure [9].
  • Patients with abnormal posterior glenoid shape are significantly more likely to progress to early failure after the CAM procedure [9].
  • The CAM procedure demonstrates significant improvements in midterm clinical outcomes and high patient satisfaction for GHOA [6].
  • The majority of patients demonstrated sustained improvement in patient-reported outcomes and satisfaction without conversion to total shoulder arthroplasty at long-term follow-up after the CAM procedure [16].
  • Some patients progressed to arthroplasty after the CAM procedure at long-term follow-up [16].
  • Arthroscopic debridement of the shoulder improves regaining external rotation in patients with osteoarthritis of the glenohumeral joint [18].
  • Arthroscopic debridement of the shoulder decreases pain in patients with osteoarthritis of the glenohumeral joint [18].
  • Arthroscopic debridement of the shoulder improves the ability to perform activities of daily living (ADLs) in patients with osteoarthritis of the glenohumeral joint [18].
  • Arthroscopic debridement and biological resurfacing of the glenoid provides pain relief, functional improvement, and patient satisfaction in glenohumeral osteoarthritis in the intermediate-term [20].

Key Evidence

  • [L4] The authors recommend a systematic, inclusive approach to the array of pathologies encountered in the setting of early glenohumeral arthritis: the Comprehensive Arthroscopic Management (CAM) procedure. [1] (10.1016/j.arthro.2022.01.033)
  • [Paper] The comprehensive arthroscopic management procedure provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis by reducing pain and improving function. [2] (10.1016/j.eats.2015.04.003)
  • [L4] The CAM procedure reduced pain, improved function, and provided reasonable short-term durability for young, active patients with advanced shoulder OA, serving as a joint-preserving alternative to arthroplasty. [3] (10.1016/j.arthro.2012.10.028)
  • [L4] The results of arthroscopic stabilization reported in the literature are variable and each technique must be analyzed individually to properly determine the role of arthroscopy in glenohuminal stabilization. [4] (10.1177/03635465000280042801)
  • [L3] Arthroscopic debridement improved clinical outcome in 68% of patients suffering from advanced OA of glenohumeral joint. [5] (10.1186/s12891-015-0741-9)
  • [L4] This study demonstrates significant improvements in midterm clinical outcomes and high patient satisfaction after the arthroscopic CAM procedure for GHOA, with a 76.9% survivorship rate at a minimum of 5 years postoperatively. [6] (10.1177/0363546516656372)
  • [L4] Treatment of glenohumeral arthritis with arthroscopic glenoid resurfacing provided superior results in this series to their previously performed arthroscopic procedure. [7] (10.1016/j.arthro.2009.04.015)
  • [L5] Clinical studies report that an arthroscopic approach to glenohumeral arthritis using various joint-preserving procedures reduces pain, improves function, and improves clinical outcome scores in the short- to mid-term follow-up period. [8] (10.5435/jaaos-d-17-00214)
  • [L3] The CAM procedure reliably improves pain and function in active patients with advanced GHOA, but patients with less joint space and abnormal posterior glenoid shape are significantly more likely to progress to early failure. [9] (10.1177/0363546516668823)
  • [L4] CAM is a reasonable option for patients with localized cartilage defects and specific radiographic findings, while HA or TSA are feasible options for those with humeral head incongruity or large anterior osteophytes. [10] (10.1530/eor-2023-0156)
  • [L3] Arthroscopic debridement is an excellent treatment for elderly patients with modest functional demands, though long-term consequences require further evaluation. [11] (10.1007/s00402-004-0738-6)
  • [L4] Although there are limited nonarthroplasty surgical options available for glenohumeral arthritis, isolated arthroscopic debridement and capsular release may not provide substantial benefit to justify its use in most patients. [12] (10.1016/j.arthro.2014.08.025)
  • [L1] This systematic review shows that arthroscopic debridement for glenohumeral arthritis lacks high-quality evidence to support its routine use. [13] (10.1016/j.arthro.2013.02.022)
  • [L4] Surgical arthroscopic repair was possible in all cases of acute or recurrent instability with well-defined exclusion criteria. [14] (10.1055/s-0032-1327656)
  • [L4] Comprehensive arthroscopic management without axillary nerve release or subacromial decompression achieves satisfactory and durable results in young patients with glenohumeral osteoarthritis. [15] (10.1007/s00167-023-07377-0)
  • [L4] The majority of patients demonstrated sustained improvement in patient-reported outcomes and satisfaction without conversion to total shoulder arthroplasty at long-term follow-up, although some patients progressed to arthroplasty. [16] (10.1177/2325967121s00213)
  • [L1] Arthroscopic treatment of glenohumeral osteoarthritis provides improvements in ROM and patient-reported outcomes with minimal complications. [17] (10.1016/j.arthro.2020.02.036)
  • [L4] Arthroscopic debridement of the shoulder has a role to play in the management of osteoarthritis of the glenohumeral joint, with the most improvement in regaining external rotation, decreasing pain, and improvement in the ability to perform ADLs. [18] (10.1016/j.arthro.2010.04.032)
  • [L4] Arthroscopic debridement with capsular release may provide a window of improved symptoms and function before deterioration of the joint leads to a more significant operation, especially in younger patients with mild or moderate osteoarthritic changes. [19] (10.1016/j.arthro.2006.11.016)
  • [L4] Arthroscopic debridement and biological resurfacing of the glenoid is a minimally invasive therapeutic option for pain relief, functional improvement and patient satisfaction, in glenohumeral osteoarthritis, in the intermediate-term. [20] (10.1007/s00167-010-1155-8)
  • [L4] The technique aims to decrease pain originating from the patellofemoral joint and related structures by eliminating pain sources from the subchondral bone and synovium. [21] (10.1016/j.eats.2021.08.021)
  • [L3] The survivorship rate at minimum 10-year follow-up was 63.2%, with humeral head flattening and severe joint incongruity identified as risk factors for failure. [22] (10.1177/0363546520962756)
  • [L4] Most perioperative costs associated with the arthroscopic treatment of glenohumeral instability are facility utilization and implant costs. [26] (10.1016/j.jseint.2020.01.006)
  • [L4] Although progressive radiographic osteoarthritic changes occur, they do not negatively influence clinical results. [27] (10.1016/j.arthro.2008.03.007)
  • [L4] After the CAM procedure we found an 84% survivorship at 3 years and 72% survivorship at 5 years. [30] (10.1177/2325967116s00104)

References

[1] Comprehensive Arthroscopic Management of Shoulder Arthritis. Arthroscopy. 2022. DOI: 10.1016/j.arthro.2022.01.033

[2] The Comprehensive Arthroscopic Management Procedure for Treatment of Glenohumeral Osteoarthritis. Arthroscopy Techniques. 2015. DOI: 10.1016/j.eats.2015.04.003

[3] Comprehensive Arthroscopic Management (CAM) Procedure: Clinical Results of a Joint‐Preserving Arthroscopic Treatment for Young, Active Patients With Advanced Shoulder Osteoarthritis. Arthroscopy. 2013. DOI: 10.1016/j.arthro.2012.10.028

[4] Arthroscopic Management of Glenohumeral Instability. The American Journal of Sports Medicine. 2000. DOI: 10.1177/03635465000280042801

[5] Relationship between probability of future shoulder arthroplasty and outcomes of arthroscopic debridement in patients with advanced osteoarthritis of glenohumeral joint. BMC Musculoskeletal Disorders. 2015. DOI: 10.1186/s12891-015-0741-9

[6] Survivorship and Patient-Reported Outcomes After Comprehensive Arthroscopic Management of Glenohumeral Osteoarthritis. The American Journal of Sports Medicine. 2016. DOI: 10.1177/0363546516656372

[7] Arthroscopic Glenoid Resurfacing: Results in Patients With Failed Previous Arthroscopic Debridement (SS‐14). Arthroscopy. 2009. DOI: 10.1016/j.arthro.2009.04.015

[8] Arthroscopic Management of Glenohumeral Arthritis: A Joint Preservation Approach. Journal of the American Academy of Orthopaedic Surgeons. 2018. DOI: 10.5435/jaaos-d-17-00214

[9] Comprehensive Arthroscopic Management of Glenohumeral Osteoarthritis: Preoperative Factors Predictive of Treatment Failure. The American Journal of Sports Medicine. 2016. DOI: 10.1177/0363546516668823

[10] Comprehensive arthroscopic management versus total shoulder arthroplasty and hemiarthroplasty in patients with primary glenohumeral arthritis younger than 50 years old. EFORT Open Reviews. 2026. DOI: 10.1530/eor-2023-0156

[11] Arthroscopic debridement of massive rotator cuff tears: negative prognostic factors. Archives of Orthopaedic and Trauma Surgery. 2004. DOI: 10.1007/s00402-004-0738-6

[12] Arthroscopic Debridement and Capsular Release for the Treatment of Shoulder Osteoarthritis. Arthroscopy. 2014. DOI: 10.1016/j.arthro.2014.08.025

[13] What Is the Role of Arthroscopic Debridement for Glenohumeral Arthritis? A Critical Examination of the Literature. Arthroscopy. 2013. DOI: 10.1016/j.arthro.2013.02.022

[14] Arthroscopic Treatment of Glenohumeral Instability in Soccer Goalkeepers. International Journal of Sports Medicine. 2012. DOI: 10.1055/s-0032-1327656

[15] Comprehensive arthroscopic management without axillary nerve release or subacromial decompression achieves satisfactory and durable results in young patients with glenohumeral osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy. 2023. DOI: 10.1007/s00167-023-07377-0

[16] Survivorship and Patient-Reported Outcomes After Comprehensive Arthroscopic Management of Glenohumeral Osteoarthritis: Minimum 10-Year Follow-up. Orthopaedic Journal of Sports Medicine. 2021. DOI: 10.1177/2325967121s00213

[17] Outcomes and Survivorship After Arthroscopic Treatment of Glenohumeral Arthritis: A Systematic Review. Arthroscopy. 2020. DOI: 10.1016/j.arthro.2020.02.036

[18] Arthroscopic Debridement and Capsular release of the Shoulder as a Treatment for Osteoarthritis of the Glenohumeral Joint (SS‐22). Arthroscopy. 2010. DOI: 10.1016/j.arthro.2010.04.032

[19] Arthroscopic Debridement and Capsular Release for Glenohumeral Osteoarthritis. Arthroscopy. 2007. DOI: 10.1016/j.arthro.2006.11.016

[20] Arthroscopic debridement and biological resurfacing of the glenoid in glenohumeral arthritis. Knee Surgery, Sports Traumatology, Arthroscopy. 2010. DOI: 10.1007/s00167-010-1155-8

[21] Arthroscopic Debridement, Facetectomy, and Synovectomy for Isolated Patellofemoral Osteoarthritis. Arthroscopy Techniques. 2021. DOI: 10.1016/j.eats.2021.08.021

[22] Survivorship and Patient-Reported Outcomes After Comprehensive Arthroscopic Management of Glenohumeral Osteoarthritis: Minimum 10-Year Follow-up. The American Journal of Sports Medicine. 2020. DOI: 10.1177/0363546520962756

[26] A single-institution analysis of factors affecting costs in the arthroscopic treatment of glenohumeral instability. JSES International. 2020. DOI: 10.1016/j.jseint.2020.01.006

[27] Arthroscopic Debridement of Massive Irreparable Rotator Cuff Tears. Arthroscopy. 2008. DOI: 10.1016/j.arthro.2008.03.007

[30] Survivorship after Arthroscopic Management of Glenohumeral Osteoarthritis with a Minimum 5 year Follow-up. Orthopaedic Journal of Sports Medicine. 2016. DOI: 10.1177/2325967116s00104

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International

Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees

Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.

Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.